Sheng Chao Wang

Direttore/Membro del Consiglio presso YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.

Patrimonio netto: 40 494 $ in data 31/05/2024

41 anni

Health Technology

Consumer Services

Profilo

Sheng Chao Wang is currently a Member-Supervisory Board at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
and HEC Pharm Co., Ltd.
He obtained his undergraduate degree from Shenyang Pharmaceutical University in 2008.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO. LTD. CLASS H 0.00%	30/06/2023	32 000 ( 0.00% )	40 494 $	31/05/2024

Posizioni attive di Sheng Chao Wang

Società	Posizione	Inizio
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Direttore/Membro del Consiglio	21/07/2017
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Sheng Chao Wang

Formazione di Sheng Chao Wang

Shenyang Pharmaceutical University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sheng Chao Wang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Health Technology

Aziende private	1
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Health Technology